PATENT CLAIM ANALYSIS

Application Number: 16143995
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "133100"]

Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccine and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.

Claim (Index 20):
The antibody of  claim 14 , wherein the antibody alone is capable of causing dendritic cells to secrete at least one of IL-6, MIP-1a, IL-12p40 or TNFalpha without prior activation of the dendritic cells.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 97.0
- Lexical Diversity: 1.61364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12718365', '14165400', '15401856', '12717778', '12717789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8279293987527566
- 35 USC 102 Novelty (BERT): 0.6881682049376951
- Combined Prediction Score: 0.8139532793712504
- Mean Citation Score: 657.786522
- Max Citation Score: 712.34326
- Similarity Product: 682.5580399164319

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test